Skip to main content

Animations

MJFF Publications

8021 - 8030 of 9038 Results
Title
Year
  • Year
  • 2015
  • 2016
  • 2017
  • 2024
  • 2023
  • 2024
  • 2024
  • 2022
  • 2022
  • 2022
  • Summary Details
    OPEN
    Title: Potential sex differences in nonmotor symptoms in early drug-naive Parkinson disease
    Journal Name: Neurology
    Publisher: Ovid Technologies (Wolters Kluwer Health)
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1212/wnl.0000000000001609
    Citation Count: 117
  • Summary Details
    OPEN
    Title: Age at onset and Parkinson disease phenotype
    Journal Name: Neurology
    Publisher: Ovid Technologies (Wolters Kluwer Health)
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1212/wnl.0000000000002461
    Citation Count: 359
  • Summary Details
    OPEN
    Title: Longitudinal CSF biomarkers in patients with early Parkinson disease and healthy controls
    Journal Name: Neurology
    Publisher: Ovid Technologies (Wolters Kluwer Health)
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by-nc-nd
    DOI - Digital Object Identifier: 10.1212/wnl.0000000000004609
    Citation Count: 152
  • Summary Details
    OPEN
    Title: ePresentations
    Journal Name: European Journal of Neurology
    Publisher: Wiley
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1111/ene.16338
    Citation Count: 0
  • Summary Details
    OPEN
    Title: Adeno-associated viral vectors for functional intravenous gene transfer throughout the non-human primate brain
    Journal Name: Nature Nanotechnology
    Publisher: Springer Science and Business Media LLC
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1038/s41565-023-01419-x
    Citation Count: 126
  • Summary Details
    OPEN
    Title: An interpretable deep learning Bayesian optimized random forest framework for the diagnosis of Parkinson's disease in structural magnetic resonance images
    Journal Name: International Journal of Imaging Systems and Technology
    Publisher: Wiley
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1002/ima.23106
    Citation Count: 4
  • Summary Details
    OPEN
    Title: Outcome Selection for Research Studies in Movement Disorders
    Journal Name: Movement Disorders Clinical Practice
    Publisher: Wiley
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1002/mdc3.14087
    Citation Count: 0
  • Summary Details
    OPEN
    Title: A Collaboration for Guiding the Rational Design of Multielement Solid Catalysts
    Journal Name: Angewandte Chemie
    Publisher: Wiley
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1002/ange.202216327
    Citation Count: 0
  • Effect of Urate-Elevating Inosine on Progression of Early Parkinson Disease
    2022
    Summary Details
    RESTRICTED
    Title: Effect of Urate-Elevating Inosine on Progression of Early Parkinson Disease
    Journal Name: JAMA
    Publisher: American Medical Association (AMA)
    Publication Date:
    Open Access(OA) Status: RESTRICTED
    License:
    DOI - Digital Object Identifier: 10.1001/jama.2021.21008
    Citation Count: 5
  • Effect of Urate-Elevating Inosine on Progression of Early Parkinson Disease—Reply
    2022
    Summary Details
    RESTRICTED
    Title: Effect of Urate-Elevating Inosine on Progression of Early Parkinson Disease—Reply
    Journal Name: JAMA
    Publisher: American Medical Association (AMA)
    Publication Date:
    Open Access(OA) Status: RESTRICTED
    License:
    DOI - Digital Object Identifier: 10.1001/jama.2021.21011
    Citation Count: 4
We use cookies to ensure that you get the best experience. By continuing to use this website, you indicate that you have read our Terms of Service and Privacy Policy.